Carolina Campolina Rebello Horta

Carolina Campolina Rebello Horta

Auto-generated profile, based on publicly available information

Carolina Campolina Rebello Horta

Universidade Federal de Minas Gerais

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2014 in Toxicon
Verified
Journal Article
Closed access
ACA.O. Carmo
A.O. Carmo
BOB.B.R. Oliveira-Mendes
B.B.R. Oliveira-Mendes
CHC.C.R. Horta
C.C.R. Horta
BMB.F. Magalhães
B.F. Magalhães
ADA.E. Dantas
A.E. Dantas
EKEvanguedes Kalapothakis
Evanguedes Kalapothakis

9 November 2015 in Molecules
Verified
Journal Article
Open access
PDF file
YTYanna Teles
Yanna Teles
CHCarolina Campolina Rebello Horta
Carolina Campolina Rebello Horta
MAMaria Agra
Maria Agra
WSWeam Siheri
Weam Siheri
MBMarie Boyd
Marie Boyd
MSMaria Souza
Maria Souza
Wissadula periplocifolia (L.) C. Presl (Malvaceae) is commonly used in Brazil to treat bee stings and as an antiseptic. The antioxidant properties of its extracts have been previously demonstrated, thus justifying a phytochemical investigation for its bioactive phenolic constituents. This has yielded five new sulphated flavonoids: 8-O-sulphate isoscutellarein (yannin) (1a); 4′-O-methyl-7-O-sulphate isoscutellarein (beltraonin) (1b); 7-O-sulphate acacetin (wissadulin) (2a); 4′-O-methyl-8-O-sulphate isoscutellarein (caicoine) (2b) and 3′-O-methyl-8-O-sulphate hypolaetin (pedroin) (3b) along with the known flavonoids 7,4′-di-O-methyl-8-O-sulphate isoscutellarein (4), acacetin, apigenin, isoscutellarein, 4´-O-methyl isoscutellarein, 7,4′-di-O-methylisoscutellarein, astragalin and tiliroside. The compounds were isolated by column chromatography and identified by NMR (1H, 13C, HMQC, HMBC and COSY) and LC-HRMS. A cell based assay was carried out to evaluate the preliminary cytotoxic properties of the flavonoids against UVW glioma and PC-3M prostate cancer cells as well as non-tumour cell lines. The obtained results showed that acacetin, tiliroside, a mixture of acacetin + apigenin and the sulphated flavonoids 2a + 2b exhibited inhibitory activity against at least one of the cell lines tested. Among the tested flavonoids acacetin and tiliroside showed lower IC50 values, presenting promising antitumor effects.

19 April 2019 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
BOBárbara Bruna Ribeiro De Oliveira-Mendes
Bárbara Bruna Ribeiro De Oliveira-Mendes
SMSued Eustáquio Mendes Miranda
Sued Eustáquio Mendes Miranda
DSDouglas Ferreira Sales-Medina
Douglas Ferreira Sales-Medina
BMBárbara De Freitas Magalhães
Bárbara De Freitas Magalhães
YKYan Kalapothakis
Yan Kalapothakis
CHCarolina Campolina Rebello Horta
Carolina Campolina Rebello Horta
The hyaluronidase enzyme is generally known as a spreading factor in animal venoms. Although its activity has been demonstrated in several organisms, a deeper knowledge about hyaluronidase and the venom spreading process from the bite/sting site until its elimination from the victim's body is still in need. Herein, we further pursued the goal of demonstrating the effects of inhibition of T. serrulatus venom (TsV) hyaluronidase on venom biodistribution. We used technetium-99m radiolabeled Tityus serrulatus venom (99mTc-TsV) to evaluate the venom distribution kinetics in mice. To understand the hyaluronidase’s role in the venom’s biodistribution, 99mTc-TsV was immunoneutralized with specific anti-T.serrulatus hyaluronidase serum. Venom biodistribution was monitored by scintigraphic images of treated animals and by measuring radioactivity levels in tissues as heart, liver, lungs, spleen, thyroid, and kidneys. In general, results revealed that hyaluronidase inhibition delays venom components distribution, when compared to the non-neutralized 99mTc-TsV control group. Scintigraphic images showed that the majority of the immunoneutralized venom is retained at the injection site, whereas non-treated venom is quickly biodistributed throughout the animal’s body. At the first 30 min, concentration peaks are observed in the heart, liver, lungs, spleen, and thyroid, which gradually decreases over time. On the other hand, immunoneutralized 99mTc-TsV takes 240 min to reach high concentrations in the organs. A higher concentration of immunoneutralized 99mTc-TsV was observed in the kidneys in comparison with the non-treated venom. Further, in situ neutralization of 99mTc-TsV by anti-T.serrulatus hyaluronidase serum at zero, ten, and 30 min post venom injection showed that late inhibition of hyaluronidase can still affect venom biodistribution. In this assay, immunoneutralized 99mTc-TsV was accumulated in the bloodstream until 120 or 240 min after TsV injection, depending on anti-hyaluronidase administration time. Altogether, our data show that immunoneutralization of hyaluronidase prevents venom spreading from the injection site. By comparing TsV biodistribution in the absence or presence of anti-hyaluronidase serum, the results obtained in the present work show that hyaluronidase has a key role not only in the venom spreading from the inoculation point to the bloodstream, but also in venom biodistribution from the bloodstream to target organs. Our findings demonstrate that hyaluronidase is indeed an important spreading factor of TsV and its inhibition can be used as a novel first-aid strategy in envenoming. Hyaluronidases are known as the venom components responsible for disseminating toxins from the injection site to the victim’s organism. Therefore, understanding how the venom distribution occurs and the role of hyaluronidases in this process is crucial in the field of toxinology. In this study, we inhibited Tityus serrulatus venom (TsV) hyaluronidase’s action using specific anti-Ts-hyaluronidase antibodies. Labeling TsV with a radioactive compound enabled monitoring of its biodistribution in mice. Our results show that, upon hyaluronidase inhibition, TsV remains at the injection site for longer, and only a reduced amount of the venom reaches the bloodstream. Consequently, the venom arrives later at target organs like the heart, liver, lungs, spleen, and thyroid. Considering the possible application of hyaluronidase inhibition as a therapeutic resource in envenoming first-aid treatment, we performed the administration of hyaluronidase neutralizing antibodies at different times after TsV injection. We observed that TsV remains in the bloodstream and its arrival at tissues is delayed by 120 or 240 min after TsV injection, depending on anti-hyaluronidase administration times. Our data show that hyaluronidase plays a crucial role in TsV spreading from the injection site to the bloodstream and from the bloodstream to the organs, thus suggesting that its inhibition can help to improve envenoming’s treatment.

1 September 2016 in Toxicon
Verified
Journal Article
Closed access
ADArthur Estanislau Dantas
Arthur Estanislau Dantas
ACA.O. Carmo
A.O. Carmo
CHCarolina Campolina Rebello Horta
Carolina Campolina Rebello Horta
HLHortênsia Gomes Leal
Hortênsia Gomes Leal
BOBárbara Bruna Ribeiro Oliveira-Mendes
Bárbara Bruna Ribeiro Oliveira-Mendes
EKEvanguedes Kalapothakis
Evanguedes Kalapothakis

1 April 2015 in Toxicon
Verified
Journal Article
Closed access
ACA.O. Carmo
A.O. Carmo
MCMaria Chatzaki
Maria Chatzaki
CHC.C.R. Horta
C.C.R. Horta
BMB.F. Magalhães
B.F. Magalhães
BOB.B.R. Oliveira-Mendes
B.B.R. Oliveira-Mendes
EKEvanguedes Kalapothakis
Evanguedes Kalapothakis

1 December 2008 in Toxicon
Verified
Journal Article
Closed access
TMT.M. Mendes
T.M. Mendes
FDF. Dias
F. Dias
CHC.C.R. Horta
C.C.R. Horta
IPI.F. Pena
I.F. Pena
Eliane Candiani ArantesEliane Candiani Arantes
Eliane Candiani Arantes
EKEvanguedes Kalapothakis
Evanguedes Kalapothakis